Insulin Degludec recalls
The FDA has published 4 recalls involving Insulin Degludec since 2021. The latest was reported on 21 Apr 2021. Most were for temperature abuse. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls4since 2021
Last 12 months0reported
Class I4100% of total
Ongoing0latest 21 Apr 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 4 100%Class II 0 0%Class III 0 0%
Why insulin degludec is recalled
Companies
Brands
By year
All insulin degludec recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Tresiba FlexTouch (insulin degludec injection)/mL recalledTresiba | Novo Nordisk | Temperature Abuse | Nationwide |
| Drug | CLASS I | Tresiba FlexTouch (insulin degludec injection)/mL recalledTresiba | Novo Nordisk | Temperature Abuse | Nationwide |
| Drug | CLASS I | Xultophy 100/3.6 (insulin degludec recalled by Novo NordiskXultophy 100/3.6 | Novo Nordisk | Temperature Abuse | Nationwide |
| Drug | CLASS I | Tresiba (insulin degludec injection)/mL (U-100) recalled by Novo NordiskTresiba | Novo Nordisk | Temperature Abuse | Nationwide |
Should you stop taking Insulin Degludec?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.